Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

Bayer gains FDA priority review for prostate cancer drug

Bayer gains FDA priority review for prostate cancer drug The move comes just two months after Bayer, and darolutamide-partner Orion, revealed positive late-stage data for the non-steroidal androgen receptor inhibitor. ... Bayer reckons that tolerability is critical in non-metastatic CRPC because patients may

Sobi shows strong growth despite haemophilia competition

Sobi shows strong growth despite haemophilia competition Another new entrant in the haemophilia A market is Bayer’s Jivi, which has a twice weekly dosing schedule.

Biotech now vital to pipelines – but success rates falling

Biotech now vital to pipelines – but success rates falling first RNA interference (RNAi) therapy and  Lox/Bayer’s NTRK gene fusion – targetting Vitrakvi (larotrectinib).

Mereo’s shareholders back OncoMed takeover

GlaxoSmithKline, Bayer and Celgene, whilst raising hundreds of millions of dollars in funding. ... GSK-partnered tarextumab for pancreatic cancer was the first casualty in 2016, followed by Celgene-partnered demicizumab a year later, and then Bayer

Chi-Med goes for third IPO in Hong Kong

Chi-Med goes for third IPO in Hong Kong It was the second VEGF inhibitor to reach the Chinese market, after Bayer’s Stivarga, and Chi-Med is partnering with Eli Lilly to commercialise the drug across China whilst also

[ Previous 5 results ] 13 14 15 16 17 18 19 20 21 22 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics